HealthyDirect · GrowthFit for a long SIP
Groww Multicap Fund
Groww Mutual FundEquity Schemes - Multi Cap Fund1.9 years
The scheme seeks to achieve long-term capital appreciation by predominantly investing in equity and equity-related instruments of large, mid and small-cap companies.
- NAV
- 12.0232
- 29 Oct 2026
- 1Y
- +10.8%
- Trailing CAGR
- AUM
- ₹1,687.35 Cr
- 30 Sept 2026
- Volatility
- Medium
- 15.6% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 1-year windows.
Buy checklist
History depth
Fail
1.9 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.02% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -16.5%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Hitesh Das · 0.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 28.1% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+10.8%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+10.3%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+14.8%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +10.3%
- Calendar-day CAGR
- Excess 1Y
- +14.8%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -16.5%
- Worst peak-to-trough
- Current
- -5.8%
- Below last peak
- Current spell
- 59 days
- Days below latest peak
- Time below peak
- +87%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 11 days
- 26 recovered episodes
- Longest recovery
- 94 days
- Trough to prior peak
2 Jan 2025 – 5 Jun 2025
Trough 3 Mar 2025 · recovered in 94 days
-16.5%
17 Nov 2025 – 16 Apr 2026
Trough 23 Mar 2026 · recovered in 24 days
-12.1%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.5%
19 Sept 2025 – 23 Oct 2025
Trough 30 Sept 2025 · recovered in 23 days
-3.8%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
46
Vs category
100
Consistency
100
Risk-adjusted
42
Drawdown
59
Mean
69
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 1-year windows.
Portfolio
30 Sept 2026 · 82 holdings · top 10 are 28.1%.
- Top 5
- 15.7%
- Top 10
- 28.1%
- Largest holding
- 3.5%
- Effective holdings
- 57.4
Reverse Repo
Unspecified
3.5%
Manipal Payment and Identity Solutions Ltd.
Industrials
3.4%
TD Power Systems Ltd
Industrials
3.1%
Ujjivan Small Finance Bank Ltd
Financial
2.9%
Hyundai Motor India Ltd.
Consumer Discretionary
2.7%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis Multicap Fund
Axis Mutual Fund
- 1Y
- +4.0%
- 3Y
- +18.9%
- Vol
- 14.0%
- Max DD
- -18.1%
- Sharpe
- 0.70
- 3Y win
- +96%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Canara Robeco Multi Cap Fund
Canara Robeco Mutual Fund
- 1Y
- -4.5%
- 3Y
- +13.4%
- Vol
- 13.9%
- Max DD
- -18.3%
- Sharpe
- 0.53
- 3Y win
- 0%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
HSBC Multi Cap Fund
HSBC Mutual Fund
- 1Y
- +0.7%
- 3Y
- +16.7%
- Vol
- 15.2%
- Max DD
- -20.1%
- Sharpe
- 0.94
- 3Y win
- +100%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
ICICI Prudential Multi Cap Fund
ICICI Prudential Mutual Fund
- 1Y
- -2.3%
- 3Y
- +13.9%
- Vol
- 15.4%
- Max DD
- -38.9%
- Sharpe
- 0.64
- 3Y win
- +26%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Kotak Multi Cap Fund
Kotak Mahindra Mutual Fund
- 1Y
- -4.1%
- 3Y
- +15.8%
- Vol
- 15.5%
- Max DD
- -21.0%
- Sharpe
- 0.63
- 3Y win
- +97%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown